RT Journal Article SR Electronic T1 Deep learning-derived age of hippocampus-centred regions is influenced by APOE genotype and modifiable risk factors JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.10.27.24316212 DO 10.1101/2024.10.27.24316212 A1 Dong, Chao A1 Pan, Yuangang A1 Thalamuthu, Anbupalam A1 Jiang, Jiyang A1 Du, Jing A1 Mather, Karen A. A1 Sachdev, Perminder S. A1 Wen, Wei YR 2024 UL http://medrxiv.org/content/early/2024/10/28/2024.10.27.24316212.abstract AB Brain age has been widely investigated by using the whole brain image. However, the age of some specific brain regions, such as those related to the hippocampus, remains underexplored. This study developed age prediction models for left and right hippocampus-centred regions of interest (hippocampus ROI) using three-dimensional convolutional neural networks (3D-CNN) based on MRI scans from 31,370 healthy participants in the UK Biobank. The hippocampus ROI age (HA) gap was calculated by subtracting chronological age from predicted HA. Additionally, the longitudinal change rate of the HA gap was estimated in 3,893 participants with imaging data at two time points over an average follow-up of 2.63 years. The models achieved state-of-the-art performance (mean absolute error (MAE): 2.47 – 2.84 years). Cross-sectional analysis revealed that APOE ε4 homozygotes had a greater HA gap compared to APOE ε4 non-carriers. Participants with hypertension, diabetes, heavy alcohol consumption, or smoking also exhibited larger HA gap. Transfer learning applied to an independent dataset confirmed similar trends in some variables, though findings were not statistically significant. Interestingly, longitudinal analysis showed that APOE ε4 homozygotes had a higher annual change rate in the left HA gap compared to APOE ε2 homozygotes. Occlusion analysis saliency maps indicated that regions around the hippocampus, including the thalamus, pallidum, nearby cerebral cortex, and white matter, significantly contributed to the age prediction. The left HA gap emerges as a potential biomarker linked to the APOE genotype and an indicator of health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Sydney Memory and Ageing Study has been funded by three National Health & Medical Research Council (NHMRC) Program Grants (ID350833, ID568969, and APP1093083).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:1. Written consent was acquired from all participants and ethics approval was provided by the National Health Service National Research Ethics Service. 2. Ethics approval was obtained from the Human Research Ethics Committees of the University of New South Wales and the South Eastern Sydney Local Health District.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.